Resolution Therapeutics Funding: $84M Raised, Series B
Resolution Therapeutics is based in Edinburgh and London, UK. It has raised $84M in total funding. Latest round: Series B. Backed by Syncona Ltd..
Resolution Therapeutics funding overview
Resolution Therapeutics is based in Edinburgh and London, UK. Resolution Therapeutics has raised $84M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2024. The round record for Resolution Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Syncona Ltd..
Resolution Therapeutics at a glance
Total raised
$84M
Latest round
Series B
Latest round date
October 2024
Headquarters
Edinburgh and London, UK
Notable investors
Syncona Ltd.
Frequently asked about Resolution Therapeutics funding
How much has Resolution Therapeutics raised?
Resolution Therapeutics has raised $84M in total disclosed funding across the rounds on record.
Who has invested in Resolution Therapeutics?
Syncona Ltd. are named among the investors backing Resolution Therapeutics.
What was the latest Resolution Therapeutics funding round?
The most recent disclosed round is a Series B, announced in October 2024.
Where is Resolution Therapeutics based?
Resolution Therapeutics is based in Edinburgh and London, UK.
When did Resolution Therapeutics last raise?
The last disclosed Resolution Therapeutics round closed in October 2024 at Series B.
We update the Resolution Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Edinburgh and London and their backers are listed below.
